For HR teams, this matters because obesity, diabetes, heart disease, and related conditions can directly affect employee health, absenteeism, productivity, disability claims, and healthcare spending
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Lancet 374:16061616 Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gmez R, Muoz RM, Eng J, Blzquez E (2000) Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats
Heres why muscle loss may occur with GLP-1 weight loss treatments : Reduced Appetite and Protein Intake GLP-1 weight loss injections suppress appetite, which can lead to an overall reduction in calorie and protein intake
Scientific American
6 Alternatively, some patients may be prescribed sulfonylureas or thiazolidiniones to improve insulin secretion, but both of these treatment options are associated with an elevated risk of heart failure making them unsuitable for use in patients with cardiovascular disease
